FUTU or ZETA: Which Is the Better Value Stock Right Now?

A comparative analysis by Zacks identifies Futu Holdings Limited (FUTU) as the superior value stock over Zeta Global Holdings (ZETA) for investors. FUTU holds a stronger Zacks Rank #2 (Buy) compared to ZETA's #3 (Hold), alongside more attractive valuation metrics including a lower forward P/E of 22.68 versus ZETA's 27.25 and a PEG ratio of 0.83 against ZETA's 1.44. This indicates stronger earnings estimate revision activity and a more compelling valuation for FUTU, positioning it as the preferred option for value-focused portfolios.

Analysis

A comparative fundamental analysis of two Technology Services stocks, Futu Holdings (FUTU) and Zeta Global Holdings (ZETA), indicates a stronger value proposition for FUTU. This assessment is based on the Zacks Rank system, where FUTU holds a #2 (Buy) rating, signifying positive earnings estimate revisions and an improving analyst outlook, compared to ZETA's #3 (Hold) rating. On a quantitative basis, FUTU exhibits more attractive valuation metrics. Its forward Price-to-Earnings (P/E) ratio stands at 22.68, below ZETA's 27.25. More significantly, FUTU's Price/Earnings-to-Growth (PEG) ratio is 0.83, a level often interpreted as undervalued relative to its growth forecast, while ZETA's PEG of 1.44 suggests a less favorable valuation. This is further corroborated by a slightly lower Price-to-Book (P/B) ratio for FUTU at 6.14 versus 6.55 for ZETA, culminating in a superior Zacks Value grade of B for FUTU against a D for ZETA.

Key Decisions for Investors

• Investors focused on value within the technology services sector should consider Futu Holdings (FUTU) due to its stronger analyst outlook, superior 'Buy' rating, and more compelling valuation metrics, particularly its PEG ratio of 0.83.
• Given Zeta Global's (ZETA) 'Hold' rating and comparatively high forward P/E and PEG ratios, it appears less attractive on a relative value basis, suggesting caution for new capital allocation.
• The primary differentiation in this analysis is earnings growth relative to price (PEG ratio), so monitoring future earnings reports and analyst estimate revisions for both companies will be critical to validate this value thesis.